Medrio

Medrio

Software Development

San Francisco, CA 10,485 followers

Powering your research potential.

About us

At Medrio, we're fueled by an ambitious vision: to improve 100 million lives by enabling secure, reliable, and efficient clinical trials. Since 2005, we have cultivated a thriving network of individuals who share a common goal of making a positive impact - including our dedicated team of Medrians, valued customers, and trusted partners. Our eClinical solutions are flexible and configurable to meet the needs of any clinical trial - from traditional to fully decentralized. Our solutions are easy to learn, easy to use, scalable and connected through one unified platform, providing unmatched efficiency, reliability, clarity and sophistication. As an employer, our core values are rooted in a customer-first approach, an A-player mindset, and a sprinkle of quirkiness to keep things fun and interesting. We are dedicated to powering the potential of clinical research - and we invite you to be a part of our mission. Visit our website to learn more, request a demo, or apply to join our team.

Industry
Software Development
Company size
51-200 employees
Headquarters
San Francisco, CA
Type
Privately Held
Founded
2005
Specialties
Electronic Data Capture (EDC), eClinical, Electronic Case Report Forms (eCRF), Electronic Patient-Reported Outcomes (ePRO), Data Management, Clinical Research Organization (CRO), Phase 1-4, patient centricity, eCOA, eSource, Clinical Trials , Easy-to-use, RTSM, Randomization and Trial Supply Management, Electronic Consent (eConsent), Electronic Data Capture (EDC), and Clinical Data Management

Locations

Employees at Medrio

Updates

  • View organization page for Medrio, graphic

    10,485 followers

    🔍 Discover how AI is revolutionizing clinical trials at SCOPE! As you're making a schedule for Day 2 (February 4th), pencil in a must-see live presentation from Medrio CEO, Nicole Latimer, and CTO, Mike Stocks. You’ll learn how AI can help you manage growing data volumes and trial complexity. Also, stop by Medrio’s booth (#228) for: 📊 An exclusive preview of Medrio’s AI-enabled reporting capabilities 🪄 Live demos and magic tricks from our Solutions team 📲 The chance to win an iPad and grab some Medrio swag Save the date for the presentation and sign up for an AI-enabled reporting preview session here: https://bit.ly/42l7ZOX

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • View organization page for Medrio, graphic

    10,485 followers

    #JPM25 in a nutshell, courtesy of Medrio's CEO Nicole Latimer! Read on for an insider look at the most buzzworthy topics, the best cocktail receptions, the biggest rumors, and the most popular fashion choices from the conference ➡️

    View profile for Nicole DuPont Latimer, graphic

    Chief Executive Officer at Medrio

    Didn't have a chance to attend #JPM25? Here is what I saw and heard... Most used phrase: "Cautiously optimistic" - a positive vibe permeated every conversation even as everyone admitted that there are still a lot of unknowns about the year ahead for healthcare and life sciences Most cited reason for optimism: diagnostics or preventative therapies driving downstream healthcare services (e.g., GLP-1s resulting in greater demand for CGMs and/or CPAP machines as patients become aware of their diabetes and/or sleep apnea; liquid biopsies driving early stage chemotherapy, radiation, or surgical interventions, AI-driven vocal pattern recognition of neurodegenerative disease increasing treatments of those patients years earlier than traditional diagnoses would, etc.) Second most used phrase: "Unless" - (as in "unless Russia decimates Ukraine, unless inflation returns, unless a recession begins, etc.) - there was no shortage of caveats regarding 2025 prognostications Biggest difference from previous years: police and security presence - with many healthcare executives on alert, there was lots of discussion about the abundant personnel, barricades, and other security measures that were omnipresent at the conference as well as at the hotels in the surrounding areas; while demonstrators were not prevalent, more passive protests - such as posters and chalked sayings - were scattered around Union Square Biggest rumor: A large company executive, concerned about personal security, insisted on meeting attendees joining him in his car and that the car remain moving at all times Best flash mob moment: Tuesday's wearing of pink to support the role of women in healthcare and life sciences leadership - The clothing color choice was backed up by great events, including those hosted by Spencer Stuart and Biocom California, that celebrated female leaders Best location for a cocktail reception: Montague Gallery - amazing art in an amazing space! Kudos to Neurocrine Biosciences for an incredible event. Most frequent location for a cocktail reception: Beacon Grand Hotel - Was it 4 or 5 that all happened simultaneously on Tuesday night? Most common demonstration of status: Bragging about the number of cocktail receptions you have been invited to and how you must attend every one of them Least useful accessory: Men's neckties - although sport coats were back, ties were nearly non-existent Most useful accessory: Your outside voice - with meetings held in crowded hotel lobbies, restaurants, and coffee shops, speaking loudly was an essential Most Instagram-able moment for most attendees: Getting into or out of a driverless Waymo car Best "surprise and delight" moment: a Mendocino Farms employee named me his customer of the day, comping my meal - in a city that prides itself on technology, this moment reminded me of how powerful human connection can be

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1
  • View organization page for Medrio, graphic

    10,485 followers

    📸🌟Add this one to the highlight reel for 2024: Medrio supported phase 3 or pivotal research for 5 FDA approvals last year. That’s 5.2% of all novel drug (50), device (30), and biologics (17) approvals! It’s inspiring to see our work contributing to the launch of innovative therapies that improve lives. As we look ahead to 2025, we’re excited to continue supporting small and mid-sized businesses on their go-to-market journeys, bringing groundbreaking diagnostic devices, biologics, and more to the people who need them most.

    • Medrio's support for FDA approvals in 2024
  • View organization page for Medrio, graphic

    10,485 followers

    According to our latest ISR Market Research report of experts running early-phase trials, 93% of studies now rely on electronic case report forms (eCRFs). This shift to eCRFs has the potential to provide sponsors with faster data access, real-time validation checks, and better data quality. Download the report for a wide range of first-hand data on technology uptake in clinical trials. And don’t miss thorough analysis from early-phase experts Nicole Latimer, Ana Palijan, Courtnay Buonomo, and Eric Hardy. 🔗 Download the whitepaper here: https://bit.ly/4hc8mzx #eCRF #ePRO #EDC #CDMS #eConsent #RTSM #ClinicalTrials #PhaseI

    • Download the report on technology usage in Phase 1 clinical trials from Medrio and ISR Market Research.
  • View organization page for Medrio, graphic

    10,485 followers

    🌟This year at SCOPE, we’re pulling back the curtain on AI. 🌟 Mark your schedule for a live presentation from Medrio CTO, Mike Stocks, and CEO, Nicole Latimer. They'll explore practical applications for balancing AI with human oversight in clinical trials. 📅 Date & Time: Tuesday, February 4, 2025, 4:25 - 4:55 p.m. ET 📖 Track: Day 2, Case Studies of AI-Powered Document Automation And don’t forget to stop by booth #228! You’ll be among the first to preview Medrio’s AI-enabled reporting, built into our CDMS/EDC, for faster, more actionable insights. Sign up for sneak peek of Medrio’s AI-enabled reporting at an in-booth session here: https://bit.ly/4h0URmi Who knows? You might even take home a prize or witness a magic trick from our Solutions team. 🪄 We can’t wait to see you in Orlando! #SCOPE #SCOPE25 #AI #ArtificialIntelligence

  • View organization page for Medrio, graphic

    10,485 followers

    The traditional CRO playbook needs an upgrade. ➡️ According to a survey by Cytiva and studioID, only 4% of biotechs were “extremely satisfied” with their CRO and CDMO partners. More than 8 in 10 said they’d switch if they had more money. Emerging biotechs and small pharma are projected to be the biggest drivers of R&D growth over the next 5 years. CROs can’t afford to lose out on this massive opportunity.  That’s why we created a new CRO playbook, helmed by Julie Tyson, Sr. Director of Clinical Operations, and Darshan Kansagara, Solutions Optimization Director at Medrio. One that can help traditional vendors evolve with the needs of emerging biotechs and small pharma. Download the guide here: https://bit.ly/3PqFRSL

    • Download the CRO's Playbook for Better Trial Operations and Sponsor Partnerships
  • View organization page for Medrio, graphic

    10,485 followers

    💭 There’s a lot of buzz around AI, but specific clinical use cases are often missing from the conversation. Without concrete examples, it can be hard to see where AI can make a positive impact on your clinical trials or where it can pose significant risks. In our eBook, discover specific use cases for AI. Learn how it can improve activities like protocol design, recruitment, and data handling. Plus, see how widely the life sciences industry uses these applications and how risky they are to implement. Download the eBook here: https://bit.ly/4fKUWt5 #AI #ArtificialIntelligence #DataManagement #DataQuality #ClinicalTrials

    • Read the eBook on AI Applications in Clinical trials
  • View organization page for Medrio, graphic

    10,485 followers

    🔎 De-risk your investment with tips from venture capital veterans. 👉 Tip #1: Accelerated development timelines are extremely desirable for investors–they mean faster returns and reduced risk. To run studies smarter and faster, biopharma companies are using a technique called high-throughput experimentation (HTE), a combination of laboratory automation and AI-driven analytical strategies that’s making it possible to conduct as many as 100x more experiments in the same time frame. Learn more about HTE and other vetted strategies biopharma companies can use to secure funding in today’s conservative market: https://bit.ly/3DHW6bJ #Biopharma #Biotech #VC #Funding #EDC #CDMS

    • No alternative text description for this image
  • View organization page for Medrio, graphic

    10,485 followers

    🔵 What a year it's been for Team Medrio! A huge thanks to everyone who chatted with us at a booth, came to see one of our live presentations, or chose Medrio as a partner on their journey to approval. From San Francisco to Boston to Copenhagen and beyond, we had so many inspiring conversations, forged so many exciting new partnerships, and laid the foundation for an even bigger year ahead. We can't wait to solve more clinical research challenges and contribute to improving more lives in 2025. ⭐ Happy New Year - let's keep the momentum going!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +2

Similar pages

Browse jobs

Funding

Medrio 4 total rounds

Last Round

Series unknown

US$ 30.0M

See more info on crunchbase